Overview
Human-tissue-driven AI biotech for neurodegenerative diseases.
Details
Verge’s CONVERGE platform uses patient tissue genomics and ML to identify neurodegeneration targets. Lead ALS program in clinical trials.
Human-tissue-driven AI biotech for neurodegenerative diseases. Verge's CONVERGE platform uses patient tissue genomics and ML to identify neurodegeneration targets. Lead ALS program in clinical trials.
Human-tissue-driven AI biotech for neurodegenerative diseases.
Verge’s CONVERGE platform uses patient tissue genomics and ML to identify neurodegeneration targets. Lead ALS program in clinical trials.
Turn AI reports into shareable sites
Publish reports & dashboards as websites
Make AI-generated reports public, stable, and easy to update — free to start.
Try Revdoku →